MAX Chat
Company Analysis KP Tissue Inc.
1. Summary
Advantages
- Dividends (8.48%) are higher than the sector average (2.98%).
- The stock's return over the last year (8.83%) is higher than the sector average (-2.91%).
Disadvantages
- Price (6.9 $) is higher than fair price (1.94 $)
- The company's current efficiency (ROE=3.53%) is lower than the sector average (ROE=48.53%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| KP Tissue Inc. | Consumer Staples | Index | |
|---|---|---|---|
| 7 days | 4.9% | -12.3% | 1.3% |
| 90 days | 3.1% | -15.7% | 11.9% |
| 1 year | 8.8% | -2.9% | 17.1% |
KPTSF vs Sector: KP Tissue Inc. has outperformed the "Consumer Staples" sector by 11.74% over the past year.
KPTSF vs Market: KP Tissue Inc. has significantly underperformed the market by -8.29% over the past year.
Stable price: KPTSF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: KPTSF with weekly volatility of 0.1699% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (6.9 $) is higher than the fair price (1.94 $).
Price is higher than fair: The current price (6.9 $) is 71.9% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (33.45) is higher than that of the sector as a whole (30.41).
P/E vs Market: The company's P/E (33.45) is lower than that of the market as a whole (46.06).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.17) is lower than that of the sector as a whole (5.68).
P/BV vs Market: The company's P/BV (1.17) is lower than that of the market as a whole (4.4).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0) is lower than that of the sector as a whole (2.14).
P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (12.96).
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0) is lower than that of the sector as a whole (10.47).
EV/Ebitda vs Market: The company's EV/Ebitda (0) is lower than that of the market as a whole (27.36).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -44.92% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-44.92%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-5.7%).
5.4. ROE
ROE vs Sector: The company's ROE (3.53%) is lower than that of the sector as a whole (48.53%).
ROE vs Market: The company's ROE (3.53%) is lower than that of the market as a whole (51.77%).
5.5. ROA
ROA vs Sector: The company's ROA (3.43%) is lower than that of the sector as a whole (19.6%).
ROA vs Market: The company's ROA (3.43%) is lower than that of the market as a whole (36.06%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (14.39%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.95%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 8.48% is higher than the average for the sector '2.98%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 8.48% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 8.48% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (286.64%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
